| 1 |
28992878 | Peginterferon alfa-2a for the treatment of chronic hepatitis C in the era of direct-acting antivirals. | 2017 Oct 15 |
1 |
| 2 |
29104462 | Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy. | 2017 |
2 |
| 3 |
29284412 | CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV. | 2017 Dec 29 |
2 |
| 4 |
26344576 | High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity. | 2016 Mar |
2 |
| 5 |
27022224 | Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1. | 2016 Mar 28 |
1 |
| 6 |
26189761 | A genetic variant in the interleukin 28B gene as a major predictor for sustained virologic response in chronic hepatitis C virus infection. | 2015 Aug |
1 |
| 7 |
26670100 | Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study. | 2015 |
1 |
| 8 |
27785282 | Impact of Interleukin 28B Genotype on the Virological Responses in Chronic Hepatitis C Treatment. | 2014 Dec |
1 |
| 9 |
23306941 | Prediction of sustained virologic response based on week 4 and week 12 response in hepatitis C virus genotype 1 patients treated with peginterferon and ribavirin: assessment in a favorable IL28B allele-prevalent area. | 2013 |
1 |
| 10 |
23321318 | Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure. | 2013 May |
1 |
| 11 |
23647954 | IL-28B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: a meta-analysis. | 2013 Jun |
3 |
| 12 |
23859951 | Viral hepatitis C gets personal--the value of human genomics to public health. | 2013 |
2 |
| 13 |
23936821 | Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients. | 2013 |
1 |
| 14 |
21932415 | Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4. | 2012 Feb |
3 |
| 15 |
22387386 | Predicting sustained viral response to hepatitis C using a rapid and simple IL28B rs8099917 genotyping assay. | 2012 Apr |
2 |
| 16 |
22432893 | Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation. | 2012 Sep |
3 |
| 17 |
22497812 | Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. | 2012 May |
2 |
| 18 |
22612303 | Meta-analysis: IL-28B genotype and sustained viral clearance in HCV genotype 1 patients. | 2012 Jul |
2 |
| 19 |
22727259 | Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b. | 2012 Sep |
1 |
| 20 |
23029188 | Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis. | 2012 |
2 |
| 21 |
21479134 | IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection. | 2011 Mar 30 |
3 |
| 22 |
21750736 | Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C. | 2011 |
1 |
| 23 |
21884576 | Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. | 2011 Aug 31 |
1 |
| 24 |
21914076 | IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma. | 2011 Oct |
1 |
| 25 |
21931540 | IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. | 2011 Sep |
1 |
| 26 |
20889274 | IL28B polymorphisms and chronic hepatitis C. | 2010 Nov |
2 |